OpenAI negotiates with Microsoft to seek new funding

NGUYỄN ĐĂNG |

OpenAI and Microsoft are re-discussing the terms of the multibillion-dollar partnership between the two sides.

According to the Financial Times, the deal is designed to allow the ChatGPT manufacturer to launch an initial public offering in the future (IPO), while protecting access to the software giant's advanced artificial intelligence models.

Microsoft, OpenAI's largest sponsor, is one of the key reasons why the startup has not been able to restructure its $260 billion enterprise, in order to move OpenAI away from its original goal of being a nonprofit organization with the mission of developing AI to " bring benefits to humanity".

An important issue in the discussions is how much equity Microsoft will receive in the restructured corporation in exchange for the more than $13 billion it has invested in OpenAI so far.

According to sources shared with the Financial Times, Microsoft and OpenAI are revising the terms, which were first drafted in 2019, when Microsoft invested $1 billion in OpenAI.

The current contract is valid until 2030 and includes Microsoft's access to OpenAI's intellectual property such as models and products, as well as sharing of proceeds from product sales.

Last week, The Information reported that OpenAI told investors that it would share a smaller portion of its revenue with the largest sponsor when the company restructured.

Under the current agreement, OpenAI has agreed to share 20% of its revenue with Microsoft until 2030.

However, after the deal expired, OpenAI only wanted to share 10% of its revenue with its commercial partner Microsoft, and they emphasized that Microsoft wanted to access OpenAI's technology after 2030.

In January 2025, Microsoft changed some terms in the deal with OpenAI after joining a joint venture with Japan's Oracle and softBank Group to build new AI data centers worth up to $500 billion in the US.

NGUYỄN ĐĂNG
TIN LIÊN QUAN

4 outstanding scientific works receive the Bao Son Award 2024

|

On the evening of May 11, the Vietnam Union of Science and Technology Associations in coordination with the Bao Son Education and Training Fund awarded prizes to 4 outstanding scientific works.

Microsoft employee banned from using DeepSeek application

|

Microsoft officially banned employees from using the DeepSeek application due to concerns about data security and propaganda risks.

OpenAI and FDA collaborate on using AI to evaluate drugs

|

OpenAI has met with the US Food and Drug Administration (FDA) to discuss the use of AI to speed up the drug evaluation process.

Gold prices drop more than 2% as US and China reach agreement on tariffs

|

According to Reuters, world gold prices fell more than 2% as risk-off sentiment returned after a temporary agreement to cut tariffs between the US and China.

HCMC opens new jobs for officials and civil servants who quit due to streamlining

|

Ho Chi Minh City has implemented many policies to support streamlined cadres, civil servants, public employees and workers such as training, job conversion and job connection.

Many centers and facilities in Binh Thuan violate extra teaching and learning when inspected

|

Binh Thuan - Violations in education and additional teaching and learning activities, some centers have been suspended, their operating licenses have been revoked, and teachers have been proposed to be handled.

Senior Lieutenant General Tran Quoc To: Many organizations and businesses collect excess personal data

|

Senior General Tran Quoc To - Deputy Minister of Public Security said that in the past, many organizations and enterprises have collected more personal data than necessary.

4 outstanding scientific works receive the Bao Son Award 2024

HẠO THIÊN |

On the evening of May 11, the Vietnam Union of Science and Technology Associations in coordination with the Bao Son Education and Training Fund awarded prizes to 4 outstanding scientific works.

Microsoft employee banned from using DeepSeek application

Anh Vũ |

Microsoft officially banned employees from using the DeepSeek application due to concerns about data security and propaganda risks.

OpenAI and FDA collaborate on using AI to evaluate drugs

NGUYỄN ĐĂNG |

OpenAI has met with the US Food and Drug Administration (FDA) to discuss the use of AI to speed up the drug evaluation process.